Currently out of the existing stock ratings of Matthew Henriksson, 4 are a BUY (100%).

Matthew Henriksson

Work Performance Price Targets & Ratings Chart

Analyst Matthew Henriksson, carries an average stock price target met ratio of 100% that have a potential upside of 17.02% achieved within 400 days. Previously, Matthew Henriksson worked at CITI.

Matthew Henriksson’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on GMED, Globus Medical at 05-Aug-2021.

Wall Street Analyst Matthew Henriksson

Analyst best performing recommendations are on GMED (GLOBUS MEDICAL).
The best stock recommendation documented was for GMED (GLOBUS MEDICAL) at 2/18/2021. The price target of $77 was fulfilled within 127 days with a profit of $13.5 (21.26%) receiving and performance score of 1.67.

Average potential price target upside

GMED Globus Medical

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 28-Jul-2026

$82

$7.81 (10.53%)

$85

1 months 17 days ago
(28-Jul-2026)

9/13 (69.23%)

$1.42 (1.76%)

366

Buy Since 18-Nov-2025

$100

$25.81 (34.79%)

$105

1 months 29 days ago
(16-Jul-2026)

33/35 (94.29%)

$19.09 (23.59%)

361

Buy Since 09-Dec-2021

$115

$40.81 (55.01%)

$120

2 months 1 days ago
(13-Jul-2026)

10/14 (71.43%)

$35.25 (44.20%)

111

Buy Since 06-Nov-2024

$100

$13.75 (15.94%)

$115

2 months 30 days ago
(15-Jun-2026)

22/25 (88%)

$22.68 (29.33%)

325

Buy Since 25-Feb-2026

$117

$30.75 (35.65%)

$114

4 months 6 days ago
(08-May-2026)

3/6 (50%)

$39.05 (50.10%)

499

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?